PDF 原檔:報告_MS_工業自動化JMTBA_20260729_original.pdf
圖片清單(已驗證 2026-07-31)
| 檔名 | size | 分類 | 親眼所見內容 |
|---|---|---|---|
MS-Automation 20260729_001.png |
66KB | 裝飾·banner | 「Asia Summer School 2026」廣告 banner,泳池與書本圖案 |
MS-Automation 20260729_002.png |
74KB | 真資料圖 | 亞德客(1590.TW)評等與目標價沿革圖,2023/07-2026/07,紅色虛線為目標價階梯(最新約 NT$2,000)、藍線為股價走勢 |
MS-Automation 20260729_003.png |
73KB | 真資料圖 | 上銀(2049.TW)評等與目標價沿革圖,2023/07-2026/07,紅色虛線為目標價階梯(最新約 NT$400)、藍線為股價走勢 |
原始內容
M July 29, 2026 05:13 PM GMT
Greater China Technology Hardware | Asia Pacific
Automation - Read-across from JMTBA June 2026 Orders
In this report, we focus on final JMTBA orders, which we believe could among the catalysts for Airtac's and Hiwin's share prices.
Per the Japan Machine Tool Builders' Association (JMTBA), headline orders grew 15% MoM and 53% YoY in June 2026 (vs. -6% MoM/+38% YoY in May 2026), to ¥203bn.
- Domestic orders +28% MoM/+46% YoY (vs. -8% MoM/+37% YoY in May), to ¥58bn.
- Overseas orders +10% MoM/+56% YoY (vs. -6% MoM/+38% YoY in May), to ¥145bn.
- By region:
- ° China: +10% MoM/+76% YoY, to ¥56bn
- ° Europe: +15% MoM/+22% YoY, to ¥19bn
- ° North America: +9% MoM/+44% YoY, to ¥41bn
Our view:
- Order growth for all three major regions remained solid on a YoY basis, pointing to a continuous up-cycle. This is consistent with manufacturing PMIs hovering above the 50 threshold, e.g., China, Europe, and North America at 50.3, 51.4, and 53.3, respectively, in June vs. 50.0, 51.6, and 54.0 in May.
- On top of the overall segment recovery within automation:
- ° Airtac (1590.TW, OW) should benefit from its own share gains and incremental contribution from linear motion components. Valuation appears undemanding at 20x 2027e P/E (vs. 25x average since 2020).
- ° Hiwin (2049.TW, OW) should show margin expansion in the coming quarters, supported by higher utilization and price hikes. We see potential share price upside as the stock now trades at 27x 2027e P/E (vs. peak cycle valuation of 35-40x).
Update
Morgan Stanley Taiwan Limited+
Derrick Yang
Equity Analyst
Derrick.Yang@morganstanley.com
+886 2 2730-2862
Vivi Huang
Research Associate
Vivi.Huang@morganstanley.com
+886 2 2730-2860
Morgan Stanley Asia Limited+
Andy Meng, CFA
Equity Analyst
Andy.Meng@morganstanley.com
+852 2239-7689

Greater China Technology Hardware
Asia Pacific Industry View
In-Line
Morgan Stanley does and seeks to do business with companies covered in Morgan Stanley Research. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of Morgan Stanley Research. Investors should consider Morgan Stanley Research as only a single factor in making their investment decision.
For analyst certification and other important disclosures, refer to the Disclosure Section, located at the end of this report.
+= Analysts employed by non-U.S. affiliates are not registered with FINRA, may not be associated persons of the member and may not be subject to FINRA restrictions on communications with a subject company, public appearances and trading securities held by a research analyst account.
M
AlphaSignals Catalyst Event Reaction
| Company / Catalyst | Date | Impact to thesis | Catalyst versus expectation |
|---|---|---|---|
| AirTAC International 1590.TW | |||
| JMTBA June 2026 Orders | 29 Jul 2026 | Unchanged | In-line |
| Hiwin Technologies Corp. 2049.TW | |||
| JMTBA June 2026 Orders | 29 Jul 2026 | Unchanged | In-line |
M
Valuation Methodology and Risks
AirTAC International (1590.TW)
Base case, 29x 2027e P/E. We believe this methodology better captures earnings growth momentum for industrial automation component plays (market sentiment moves along with business cycles). As the industry enters an up-cycle, we think applying a near-peak cycle valuation of 29x P/E is reasonable given the stronger business outlook.
Risks to Upside
- n Stronger macroeconomic climate in China
- n Stronger-than-expected demand from industrial automation
Risks to Downside
- n Sharper economic downturn in China
- n Miniature linear guideway business development taking more time
- n Larger-than-expected investment in new products but weaker-than-expected demand
Hiwin Technologies Corp. (2049.TW)
Base case, P/E. We think this valuation methodology better captures Hiwin's earnings growth momentum, as its valuation tends to move with the business cycle. We apply a target multiple of 37x to our 2027 EPS estimate. We view this multiple as justified by the 44% operating profit CAGR we project for 2025-28.
Risks to Upside
- n Stronger industrial automation demand pickup.
- n Market share gains.
- n Earlier-than-expected revenue contribution from humanoids.
Risks to Downside
- n Weaker industrial automation demand.
- n More pricing pressure.
- n Market share loss.
- n More broad-based impact on the global economy from geopolitical risks.
M
Disclosure Section
The information and opinions in Morgan Stanley Research were prepared or are disseminated by Morgan Stanley Asia Limited (which accepts the responsibility for its contents) and/or Morgan Stanley Asia (Singapore) Pte. (Registration number 199206298Z) and/or Morgan Stanley Asia (Singapore) Securities Pte Ltd (Registration number 200008434H), regulated by the Monetary Authority of Singapore (which accepts legal responsibility for its contents and should be contacted with respect to any matters arising from, or in connection with, Morgan Stanley Research), and/or Morgan Stanley Taiwan Limited and/or Morgan Stanley & Co International plc, Seoul Branch, and/or Morgan Stanley Australia Limited (A.B.N. 67 003 734 576, holder of Australian financial services license No. 233742, which accepts responsibility for its contents), and/or Morgan Stanley Wealth Management Australia Pty Ltd (A.B.N. 19 009 145 555, holder of Australian financial services license No. 240813, which accepts responsibility for its contents), and/or Morgan Stanley India Company Private Limited having Corporate Identification No (CIN) U22990MH1998PTC115305, regulated by the Securities and Exchange Board of India ('SEBI') and holder of licenses as a Research Analyst (SEBI Registration No. INH000001105); Stock Broker (SEBI Stock Broker Registration No. INZ000244438), Merchant Banker (SEBI Registration No. INM000011203), and depository participant with National Securities Depository Limited (SEBI Registration No. IN-DP-NSDL-567-2021) having registered office at Altimus, Level 39 & 40, Pandurang Budhkar Marg, Worli, Mumbai 400018, India; Telephone no. +91-22-61181000; Compliance Officer Details: Mr. Tejarshi Hardas, Tel. No.: +91-22-61181000 or Email: tejarshi.hardas@morganstanley.com; Grievance officer details: Mr. Tejarshi Hardas, Tel. No.: +91-22-61181000 or Email: msic-compliance@morganstanley.com which accepts the responsibility for its contents and should be contacted with respect to any matters arising from, or in connection with, Morgan Stanley Research, and their affiliates (collectively, "Morgan Stanley"). Morgan Stanley India Company Private Limited (MSICPL) may use AI tools in providing research services. All recommendations contained herein are made by the duly qualified research analysts.
For important disclosures, stock price charts and equity rating histories regarding companies that are the subject of this report, please see the Morgan Stanley Research Disclosure Website at www.morganstanley.com/eqr/disclosures/webapp/generalresearch, or contact your investment representative or Morgan Stanley Research at 1585 Broadway, (Attention: Research Management), New York, NY, 10036 USA.
For valuation methodology and risks associated with any recommendation, rating or price target referenced in this research report, please contact the Client Support Team as follows: US/Canada +1 800 303-2495; Hong Kong +852 2848-5999; Latin America +1 718 754-5444 (U.S.); London +44 (0)20-7425-8169; Singapore +65 6834-6860; Sydney +61 (0)2-9770-1505; Tokyo +81 (0)3-6836-9000. Alternatively you may contact your investment representative or Morgan Stanley Research at 1585 Broadway, (Attention: Research Management), New York, NY 10036 USA.